Applied Nanotech Licence Epoxy-Carbon Nanotube Technology for Use in Sporting Equipment

Applied Nanotech Holdings, Inc. (OTC BB: APNT) announced that it has entered into a License and Research and Development agreement related to its carbon nanotube composite technology (epoxy/CNT) with a prominent sporting goods manufacturer. This agreement follows the successful research + development project, which resulted in a license agreement for tennis and badminton racquets in October 2008, with the same manufacturer.

This purpose of this research agreement is to extend the previous license agreement by tailoring Applied Nanotech's patented epoxy/CNT nanocomposite technology for use in a specific new sporting goods application in order to further improve the product performance. Applied Nanotech has received $250,000 for the research portion of this agreement.

Upon successful completion of the project, the sporting goods manufacturer has an option to license the technology for certain predefined terms, including an initial license fee and ongoing royalty payments, on an exclusive basis in specific territories and on a nonexclusive basis worldwide. The project is expected to be concluded, and the initial license payment received, no later than November 30, 2010.

"Our aim is to provide our partner with fiber reinforced plastics (FRP) technology with mechanical improvements that will allow them to design and introduce new products, which are lighter and more attractive," said Dr. Zvi Yaniv, CEO of Applied Nanotech, Inc. "Currently we achieved over 30% improvement in flexural strength of FRPs, which is equivalent to the realization of between 10% and 20% lighter products while preserving their mechanical strength."

"Composites are becoming an increasingly important area of our business," said Doug Baker, CEO of Applied Nanotech Holdings, Inc. "We are pleased that our partner is continuing its high level of interest in our technology. Expansion of our agreement from tennis and badminton racquets to other sporting good applications dramatically increases the revenue potential for us."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.